化合物B02 T4656

Product Introduction
Bioactivity


英文名: RAD51 Inhibitor B02

描述: RAD51 Inhibitor B02 (B02) 是一种人 RAD51的抑制剂，IC50值为27.4 μM。

体外活性: RAD51 Inhibitor B02 specifically inhibits human RAD51 (IC50=27.4 μM), but not its E. coli homologue RecA (IC50>250 μM).The combination of B02 with cisplatin has the strongest killing effect on the human breast cancer cells MDA-MB-231.

体内活性: B02 significantly enhances the therapeutic effect of cisplatin on tumor cells in vivo. B02 is tolerated by mice at doses up to 50 mg/kg without obvious body weight loss. No inhibition of tumor growth is observed on mice solely treated by B02; whereas mice treated with 4 mg/kg cisplatin show a 33% inhibition of tumor growth. Finally, mice treated with 50 mg/kg B02 and 4 mg/kg cisplatin shows a 66% inhibition of tumor growth[2].

存储条件: Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度: DMSO : 33.9 mg/mL(100 mM)


关键字: RAD51 Inhibitor B02 | B 02 | Apoptosis | RAD-51 Inhibitor B02 | RAD51 | Inhibitor | B-02 | inhibit

相关产品: Ziyuglycoside II | Methyl 3,4-dihydroxybenzoate | Decitabine | Neferine | Sodium dichloroacetate | Isoalantolactone | 2-Hydroxychalcone | Dauricine | PYR-41 | STM2457

相关库: Anti-Aging Compound Library | Cell Cycle Compound Library | Anti-Cancer Compound Library | Bioactive Compounds Library Max | Inhibitor Library | DNA Damage & Repair Compound Library | Apoptosis Compound Library | Target-Focused Phenotypic Screening Library | Bioactive Compound Library

化合物B02 T4656信息由TargetMol中国为您提供，如您想了解更多关于化合物B02 T4656报价、型号、参数等信息，欢迎来电或留言咨询。

注：该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案，不可用于临床诊断或治疗等相关用途